Our work with patient organisations
The work of patient organisations is vital to the lives of people with healthcare needs and their families.
Partnerships between the pharmaceutical industry and patient advocacy groups are central to the pursuit of better health outcomes.
Working cooperatively with patient organisations is fundamental to understanding patients' perspectives. We are committed to putting the patient voice at the heart of all we do.
Advocacy partnership typically involves a focus on one or more of the following areas:
Access to medicines and medical devices
Shaping health policy
Improving diagnostic pathways and patient journeys
Forward together, aiming high
On behalf of patients, we have high expectations to collaborative advocacy among all stakeholders: pharmaceutical companies, policymakers, research bodies, clinicians, and patient advocacy groups. Our ambitions for advocacy partnership:
Historically, patient organisations have experienced barriers to their full participation in collaboration with their many stakeholders. We recognise the challenges that patient organisations face and want to help overcome them. Only this way can collaborative advocacy bring about the best outcomes for patients.
What to expect from us
Date of Preparation January 2023